InvestorsHub Logo
Followers 8
Posts 628
Boards Moderated 0
Alias Born 05/26/2021

Re: None

Friday, 05/06/2022 9:12:59 AM

Friday, May 06, 2022 9:12:59 AM

Post# of 13742
“We will see an explosion of information about venoms and venomous animals in the next 10 years or so.“
—Glenn King

Sooooo many good things in the pipelines for venom pharmaceuticals… in our lifetime we are so fortunate we will get to see many advancements in this sector …

… MedolifeRx, in my opinion, is poised with all the potential to be among those in the forefront of the venom candidates …

Interesting read :
https://www.pnas.org/doi/10.1073/pnas.2004486117

“Venom back in vogue as a wellspring for drug candidates
How a new wave of research on venoms from an array of creatures could seed future pharma development.”
================================
***also : CC sign up REMINDER***
QNTA announced that it has scheduled a conference call with investors for Thursday, May 12

To register for this call, please use the below web link:
https://us06web.zoom.us/webinar/register/WN_oPsR6XT3QOyuze3yp-eZyQ

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>
If you have questions, please send an email to ir@medoliferx.com
with ‘QNTA Question’ in the subject line
by NOON Eastern Daylight Time on Wednesday, May 11.
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^

The Company will answer as many questions as time will allow. For those unable to participate in the live webcast, an archived version of the webcast will be available in the following days.
*************************************************
https://ir.stockpr.com/buyquanta/sec-filings-email/content/0001493152-22-011986/ex99-1.htm
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^

QNTA MedolifeRx AELIA escozine

https://medoliferx.com/shop/drops/escozine-immunapen-original-drops/

https://aeliastore.com/

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.